GL1X · GenesisL1 explorer

Research workbench

Crystal structure of botulinum neurotoxin serotype D ligand binding domain in complex with N-acetylneuraminic acid

Analyse Crystal structure of botulinum neurotoxin serotype D ligand binding domain in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3OBT
Type
protein
Length
412 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type D
EC
3.4.24.69
UniProt
P19321
Ligands
SLB
Pockets
3 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 8% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type D (EC 3.4.24.69)protein4128% helix, 44% strandP19321

Ligands and binding sites

  • SLB · N-acetyl-beta-neuraminic acid · sugar · chains A
  • GOL · Glycerol · additive · 11 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12020.760.9136empty
21920.560.8031empty
3670.300.7416empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 3OBT · Crystal structure of Botulinum neurotoxin serotype D ligand binding domain in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.